Bi-allelic REN Mutations and Undetectable Plasma Renin Activity in a Patient With Progressive CKD
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu kazuistiky, časopisecké články
PubMed
37180515
PubMed Central
PMC10166736
DOI
10.1016/j.ekir.2023.01.017
PII: S2468-0249(23)00018-9
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
Department of Nephrology and Renal Transplant Hospital de Santa Maria CHULN EPE Lisbon Portugal
Genetic Department of Hospital de Santa Maria CHULN EPE Lisbon Portugal
GenoMed Diagnósticos de Medicina Molecular S A Lisbon Portugal
Section on Nephrology Wake Forest School of Medicine Winston Salem North Carolina USA
Zobrazit více v PubMed
Sparks M.A., Crowley S.D., Gurley S.B., et al. Classical renin-angiotensin system in kidney physiology. Compr Physiol. 2014;4:1201–1228. doi: 10.1002/cphy.c130040. PubMed DOI PMC
Gribouval O., Gonzales M., Neuhaus T., et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet. 2005;37:964–968. doi: 10.1038/ng1623. PubMed DOI
Zivna M., Kidd K., Zaidan M., et al. An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes. Kidney Int. 2020;98:1589–1604. doi: 10.1016/j.kint.2020.06.041. PubMed DOI PMC
Fila M., Morinière V., Eckart P., et al. Bi-allelic mutations in renin-angiotensin system genes, associated with renal tubular dysgenesis, can also present as a progressive chronic kidney disease. Pediatr Nephrol. 2020;35:1125–1128. doi: 10.1007/s00467-020-04524-4. PubMed DOI
Bleyer A.J., Zivná M., Hulková H., et al. Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone. Clin Nephrol. 2010;74:411–422. doi: 10.5414/cnp74411. PubMed DOI PMC
Centers for Disease Control and Prevention Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987–1995. Morb Mortal Wkly Rep. 1997;46:240–242. PubMed
Dilliott A.A., Wang J., Brown E., et al. A novel homozygous variant in REN in a family presenting with classic features of disorders involving the renin-angiotensin pathway, without renal tubular dysgenesis. Am J Med Genet A. 2020;182:2284–2290. doi: 10.1002/ajmg.a.61780. PubMed DOI
Campbell D.J. Clinical relevance of local renin angiotensin systems. Front Endocrinol (Lausanne) 2014;5:113. doi: 10.3389/fendo.2014.00113. PubMed DOI PMC
Eckardt K.U., Alper S.L., Antignac C., et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--a KDIGO consensus report. Kidney Int. 2015;88:676–683. doi: 10.1038/ki.2015.28. PubMed DOI